- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT02440386
iLink (Incentives for Linkage to ART) Study: A Mixed-methods Study to Improve Linkage to HIV Care (iLink)
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
The initiation of combination antiretroviral therapy (ART) remains a serious challenge globally, and particularly in South Africa, the country with the largest population of people living with HIV worldwide (UNAIDS 2012). South Africa has the largest ART programme globally, yet only half of those needing ART in South Africa were receiving treatment in 2011 (Johnson 2012). Early initiation of ART improves treatment outcomes and reduces AIDS-related morbidity and mortality. Recent studies have demonstrated a secondary benefit of ART in preventing HIV transmission by reducing viral load and thus transmissibility (Cohen et al. 2011; Montaner et al. 2010; Tanser et al. 2013). Despite the personal and public health benefits of ART, South African studies have shown large loss to follow-up at each of the stages required for ART initiation: (1) initial CD4 count testing and returning for results; (2) attending ART readiness counselling; and (3) returning to initiate ART (April et al. 2009; Bassett et al. 2010; Kranzer et al. 2010; Larson et al. 2010; Losina et al. 2010).
Novel interventions are urgently needed to improve linkage to HIV treatment and care post-diagnosis, as increased ART coverage will reduce AIDS-related morbidity and mortality, and HIV incidence. Improving ART coverage is therefore a priority in many regions of the world, and particularly in sub-Saharan Africa, where AIDS remains a key development challenge. Interventions based on theories from the field of behavioural economics, a hybrid of principles from psychology and economics (Bickel et al. 1995), have great potential to help strengthen the contributions of psychology to improving ART outcomes. Conditional economic incentives (CEIs), a financial incentive given upon completion of an outcome that can be objectively measured (i.e. ART initiation), has the potential to leverage two theoretical principles from behavioural economics to improve ART initiation. First, instead of being completely rational and accurate, decision-making is viewed as inherently biased due to a multitude of social-cognitive and affective factors that play a role in cost-benefit analysis, such as emotions, personal beliefs, and contextual factors (Fiske & Taylor 2008). In other words, people's preferred outcomes are largely determined by salient contextual needs (Operario et al. 2013). Second, people have a tendency to give greater value to rewards in the present or near future than those in the more distant future (a phenomenon economists term temporal discounting) and therefore decision-making favours immediate rewards and heavily discounts future outcomes. This poses a challenge for ART initiation as the future benefits of ART may be valued less than an individual's more immediate needs, especially for individuals who currently perceive themselves to be relatively healthy.
A CEI may help overcome this challenge for ART initiation by increasing its immediate benefits. A CEI may therefore help 'nudge' individuals to initiate ART by altering the cost-benefit ratio so that the benefits of ART (i.e. the immediate financial reward and the future health reward) outweigh the immediate costs of ART initiation, such as transport, time off work, long waiting lines and the fear of stigma. The application of CEIs to address HIV prevention and treatment problems is still in its infancy, but they have been successfully employed to improve adherence to ART (Rosen et al. 2007; Sorensen et al. 2007; Javanbakht et al. 2010), increase HIV testing uptake and the collection of HIV tests results (Thornton 2008), and reduce risky sexual behaviours (Baird et al. 2012). This evidence indicates that small incentives-based interventions can 'nudge' individuals towards adopting healthier behaviours.
The proposed research will make a significant contribution to our knowledge about demand creation for HIV treatment and prevention services by examining whether CEIs may also be an effective tool for improving linkage to HIV treatment and care following referral for ART services. The proposed research will examine the feasibility and acceptability of using CEIs to increase the uptake of ART among men and women who are referred for ART services. Our long-term collaborative goal is to utilize the results from this pilot study to prepare a grant application for a fully-powered RCT examining whether CEIs can increase ART initiation.
Objectives To examine the acceptability and feasibility of an incentive intervention aimed at increasing uptake of ART among men and women who are referred for ART (CD4 < 500 or WHO stage 4) by a mobile health clinic.
Acceptability
- Did participants find the randomization process fair and acceptable?
- Was the intervention an incentive that motivated or encouraged uptake of ART?
- Was the incentive amount and type acceptable?
- Were individuals in the control arm discouraged from ART initiation because they felt that their linkage to care efforts were not rewarded?
- Were there cases of patients who were unsatisfied or disappointed as a consequence of the study (eg. they did not receive the incentive, yet they thought they should)?
Feasibility
- Is it possible to recruit men and women into the study on the day of being referred for ART?
- Is it possible to track individuals and recruit individuals for in-depth interviews?
Is it possible to implement the study as planned:
- Did the randomization process work?
- Did participants understand the incentive system?
- Did participants believe that they would actually receive the incentive?
- Did the incentive delivery method work?
- What is the potential for individuals to game the incentive system? Did any individuals find a method of receiving the money without starting ART?
Potential Efficacy
- Is ART initiation more likely among men and women who are offered the incentive compared to men and women who are not offered the incentive?
- Is early ART initiation more likely among men and women who are offered the incentive compared to men and women who are not offered the incentive?
- Does retention in care after ART initiation differ among men and women who are offered the incentive compared to men and women not offered the incentive?
- What is the potential for incentives to improve ART initiation given participants behavioural intentions regarding ART initiation and barriers to ART initiation?
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Western Cape
-
Cape Town, Western Cape, Sudáfrica, 7705
- Tutu Tester Mobile Clinic, Desmond Tutu HIV Foundation
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Referred for ART by the Tutu Tester Mobile Clinic (CD4 ≤ 500 or WHO stage 4)
- Planning to live in the study area for the next 6 months
- Willing and able to provide written informed consent for study participation
- Willing to accept calls from the study staff
Exclusion Criteria:
- Participated in the study previously
- Previously been on ART
- Intoxicated at the time of enrolment
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación de un solo grupo
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
---|---|
Sin intervención: Control
The control arm receives standard of care.
Standard of care involves referral for ART services and follow-up calls (maximum of 6) to assess whether linkage to care has occurred.
|
|
Experimental: Incentive
The incentive arm receives standard of care plus a R300 voucher.
The R300 voucher can be exchanged for cash if the participant starts ART at any clinic of their choice within three months from study enrollment.
|
Individuals in the intervention arm will receive the standard of care. In addition, individuals in the intervention arm receive a voucher worth R300. They are told that they will get this money if they:
Otros nombres:
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
ART initiation
Periodo de tiempo: 3 months
|
Commencement of antiretroviral therapy for HIV
|
3 months
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Time to ART initiation
Periodo de tiempo: 1-52 weeks
|
Days between referral for ART and ART initiation
|
1-52 weeks
|
Linkage to Care: first visit to clinic
Periodo de tiempo: 3 months
|
Self-reported attendance at an HIV/ART clinic within 3 months of study enrollment
|
3 months
|
Time to linkage to care
Periodo de tiempo: 1-52 weeks
|
Days between referral for ART and attendance at an HIV/ART clinic
|
1-52 weeks
|
ART retention
Periodo de tiempo: 12 months
|
Indicator of whether the participant collected his/her ART 1 year after starting treatment
|
12 months
|
Feasibility - accrual percentage
Periodo de tiempo: 6 months
|
Number of people enrolled in study/number approached for enrollment
|
6 months
|
Feasibility - participant tracking
Periodo de tiempo: 3 and 6 months post enrolment
|
Number of participants contact at 3 and 6 months/number of participants enrolled
|
3 and 6 months post enrolment
|
Acceptability - adverse events
Periodo de tiempo: 6 months
|
Unexpected risks/harms of providing incentives as self-reported by participants
|
6 months
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Brendan Maughan-Brown, PhD, University of Cape Town
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio
Finalización primaria (Actual)
Finalización del estudio (Anticipado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Estimar)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Otros números de identificación del estudio
- HRECREF:849/2014
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre VIH
-
Icahn School of Medicine at Mount SinaiIRRASReclutamientoHemorragia Intraventricular (HIV)Estados Unidos
-
Yale UniversityTerminadoPrecocidad | Recién nacidos de muy bajo peso al nacer | Hemorragia Intraventricular (HIV) | Sangrado en el cerebroEstados Unidos
-
China Medical University HospitalDesconocidoDisplasia broncopulmonar | Bebés extremadamente prematuros | TLP grave que las terapias convencionales han fallado | Sin anomalías congénitas graves | no Hiv Severa Ni FPV QuísticaTaiwán